Bayer to acquire Schiff for $1.2bn
Big money was also on the table with the proposed acquisition of Schiff Nutrition by pharma giant Bayer for a whopping $1.2 billion.
Utah-based Schiff does 90% of its business in the US and has brands like the krill omega-3 offering, MegaRed; the glucosamine joint health product Move Free; and immunity supplement, Airborne, which it acquired in March this year.
The deal is subject to regulator approval, with any potential anti-trust issues to be considered by the Federal Trade Commission (FTC).